Member Info for Bigwil7

Why? Please explain, tia.

Most RNS relating to MED2002 arrive on the 3rd working day of the week. Maybe we will hear about the PK study tomorrow.

Oh ye of little faith! (but I understand why). They've had their hands tied up until last year but the PD for the CS project changes everything. Throw in the completion of the sale of the travel business, clearing most debt in the process and the future is much more positive. Being caught up in the past with the future prospects about to change so dramatically is blinkered IMHO. The market is understandably cautious but over so by a long way. everything will change for the better once the travel business disposal completes and that's not too far away IMHO.

And two of the four largest investors are directors of Loyalward the subsidiary of Minoan used specifically for the CS project in Crete. The main two on the bod have hefty options that click in when the Min share price reaches 50p so they will be pushing hard for a nice retirement pressie. But the share price has to hit 50p first. Consider that one too.

Will be with us on Friday (apparently).

Yes the last RNS said that they were "expected" by the month end, whatever they mean by expected was a little bit vague but I hope they arrive by this Thursday. Update on the sale of the travel business and progress on their Cavo Sidero development also expected but a must IMV.

What's in a word? 'Largely' debt free has now become 'substantially' debt free. Which obviously means the amount they are to receive on the sale of the travel business is more than what they were expecting in Dec. And what does 'substantially' debt free mean exactly? Does it mean there will be substantial amounts of cash in the bank or 'more or less' no debt but there will be a small amount of debt after the sale completes??

They've got a possible partner interested in a major part the CS project, that part sounds good to me.

Nothing to do with Accord Healthcare I presume?? 'Accord Healthcare brings jobs & fresh start to Newcastle at former Sanofi site'.

Hello Rhodi. Please could you explain your location suspicions, I'm at a loss!

Correction to the last message. I think the share price should rerate to 4.4p and 8.8p given pbt of �1M and �2M and a PE of 10. Apologies I was too high initially at 22p and 44p. But you never know!

Am I right on this?? UVEL Mr Koo has stated this new contract will increase profitability considerably. PE ratios of similar cos seem to be between 10 & 20. If earnings rose to �1m next year a PE ratio of 10 would give a market cap of �84m, share price of 22p. If earnings rose to �2m (say the year after next ye 31/3/19) a PE ratio of 10 would give a market cap of �168M, share price of 44p. So if the profit increases to �1M pa the share price should rerate up from current 2.2p to 22p or there or thereabouts.

Probably recorded initially as 27p rather than 47p - ie admin error.

2 50K buys thinks so as well, possibly.

Any RNS about Med2002 has dropped on a Wednesday 7.00am (apart from the one on 4/1 which would have been a Wed had it not been for the BH!) therefore could we hear about the PK study results tomorrow? Prob to early IMHO as JB has said results will be out by end of Q1. He's getting the accounts out with presumably a whole raft of updates Wed week which is a couple of weeks earlier than last year. Gives him a couple of weeks wiggle room for the PK study update or will it be tomorrow??

Gave the mm's an early morning attendance and they then sent the price shooting up as I was trying to buy. But its retreated back down again now.

Think you are right Reflex. Difficult to buy early on but I bought 25K in dribs & drabs (5K at a time was all that was allowed)early on and they haven't shown up yet.

Great posting thomasbrowne. Spells out the potential for all to see and FUM IMHO is still at far too low at 46p. We will see tomorrow whether the buying spree will continue as per the last 3 days which will only mean less shares available and the share price will rocket. Momentum in every way is building. The Med 2002 gel must surely be a winner on all fronts. Need the results to be favourable in the PK study, no hiccups there hopefully and then it will be on to a lucrative licencing deal and the start of phaseIII and if that's a success then move on swiftly to OTC sales. It really does seem to have billion $ potential.

I am holding tight to my shares too, thomasbrowne. Tried to buy some more earlier today and couldn't get any for a while.50% of the co is in safe hands and many others have bought recently and holding on tight building a position, which doesn't leave much wiggle room when the push is on to buy as it has been recently. The share price can only react faster and faster upwards as a result. The market cap is far too low IMHO. Excellent post goldust88 you have summed up the state of play very well.The potential or part of it anyway is very near to being realised. Med2002 gel OTC should also equate to massive income from not only those with ED but perfectly heathy individuals also and that will be the final part of the potential realised (but its a few years off). Hope it all works according to plan, it seems that JB has a list in front of him and is just starting to put each part of the jigsaw into place. The year end accounts should have a few post balance sheet events to mention too although it might be too early for the main prize licencing deal for Med2002 gel. Generally there are a few RNS imbetween notification and presenting the figures - anticipation next week for some news is feeding the buying.

Apart from one time any info/news about Med2002 has arrived on a Wednesday7.00am though judging by the inactivity it doesn't seem like the PK study results will be tomorrow. Very quiet day same as yesterday.